Related Experiment Video

Updated: Jun 27, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms?

Jingxuan Pan1, Enlin Song, Chao Cheng

  • 1Department of Pathophysiology, Sun Yat-Sen University Medical School, Guangzhou, PR China. jingx_pan@yahoo.com.cn

Autophagy
|December 11, 2008
PubMed

Insights

Farnesyltransferase inhibitors (FTIs) induce autophagy in cancer cells, a likely class effect. This study explores mechanisms beyond Ras-mediated pathways, including reactive oxygen species and DNA damage, contributing to their antitumor activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Farnesyltransferase inhibitors (FTIs) target Ras oncoproteins, crucial for cancer cell proliferation.
  • The antitumor effects of FTIs are increasingly attributed to off-target actions.
  • Autophagy induction by FTIs has been recently observed in cancer cells.

Purpose of the Study:

  • To investigate the induction of autophagy by FTIs as a potential pharmacological class effect.
  • To explore alternative mechanisms, beyond Rheb-mediated mTOR regulation, that mediate FTI-induced autophagy.

Main Methods:

  • Testing three distinct FTIs across a panel of tumor cell lines.
  • Dose-dependent analysis of autophagy induction.
  • Investigating potential mechanistic pathways including reactive oxygen species, DNA damage, and Ras-mediated signaling.

Main Results:

  • Consistent induction of autophagy across multiple tumor cell lines treated with different FTIs.
  • Autophagy induction was observed in a dose-dependent manner.
  • Identified reactive oxygen species, DNA damage, and Ras-mediated pathways as potential contributors to autophagy.

Conclusions:

  • Autophagy induction is a likely pharmacological class effect of farnesyltransferase inhibition.
  • FTI-induced autophagy may involve multiple pathways, offering alternative therapeutic strategies.
  • Further research into these mechanisms could enhance FTI-based cancer therapies.

More Related Videos

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells09:34

The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells

Published on: July 27, 2018

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...